Royal London Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.1M | Sell |
|
|||||
|
2025
Q1 | $105M | Buy |
|
|||||
|
2024
Q4 | $85.3M | Buy |
|
|||||
|
2024
Q3 | $119M | Buy |
|
|||||
|
2024
Q2 | $121M | Sell |
|
|||||
|
2024
Q1 | $128M | Buy |
|
|||||
|
2023
Q4 | $110M | Buy |
|
|||||
|
2023
Q3 | $100M | Buy |
|
|||||
|
2023
Q2 | $98.1M | Buy |
|
|||||
|
2023
Q1 | $78.3M | Buy |
|
|||||
|
2022
Q4 | $84.4M | Buy |
|
|||||
|
2022
Q3 | $74.2M | Sell |
|
|||||
|
2022
Q2 | $82.8M | Sell |
|
|||||
|
2022
Q1 | $85.8M | Buy |
|
|||||
|
2021
Q4 | $72.7M | Sell |
|
|||||
|
2021
Q3 | $62.5M | Buy |
|
|||||
|
2021
Q2 | $63.8M | Sell |
|
|||||
|
2021
Q1 | $63.2M | Buy |
|
|||||
|
2020
Q4 | $54.5M | Buy |
|
|||||
|
2020
Q3 | $43.3M | Sell |
|
|||||
|
2020
Q2 | $54.4M | Buy |
|
|||||
|
2020
Q1 | $34.3M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $35.4M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $42.1M | Buy |
|
|||||
|
2018
Q4 | $36.1M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $8.02M | Buy |
|
|||||
|
2014
Q2 | $7.3M | Sell |
|
|||||
|
2014
Q1 | $7.04M | Sell |
|
|||||
|
2013
Q4 | $6.53M | Sell |
|
|||||
|
2013
Q3 | $6.17M | Buy |
|
|||||
|
2013
Q2 | $5.99M | Buy |
|